The diabetic phenotype is conserved in myotubes established from diabetic subjects: evidence for primary defects in glucose transport and glycogen synthase activity
Beharier O, Tyurin VA, Goff JP, Guerrero-Santoro J, Kajiwara K, Chu T, et al
10.1007/978-3-7091-0932-8_10 64 KanamaruY.SekineS.IchijoH.TakedaK
Regulators, therefore, treat it differently from medications requiring strict prescriptions
The clinical trials supporting GLP-1 medications didn't include antioxidant supplementation, and post-market real-world data hasn't identified oxidative stress as a limiting factor in treatment outcomes
Many mass-market supplements contain "flow agents" like magnesium stearate or silicon dioxide, along with artificial flavors and colors